Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOX | P28300 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14719693 | 0.97 | LMNA (0.36) | LOXAOC3SMN1; SMN2LMNATSHR | |
| SCHEMBL988557 | 0.90 | TSHR (0.32) | TSHRALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL2722072 | 0.87 | SMN1; SMN2 (0.38) | SMN1; SMN2LMNATSHRALDH1A1HSD17B10 | |
| 1-Hexanol SCHEMBL7675083 | 0.85 | LMNA (0.59) | SMN1; SMN2LMNATSHRALDH1A1HSD17B10 | |
| Decanol SCHEMBL7661100 | 0.85 | LMNA (0.59) | SMN1; SMN2LMNATSHRALDH1A1HSD17B10 | |
| SCHEMBL2722135 | 0.84 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNATSHRALDH1A1HSD17B10 | |
| SCHEMBL7784473 | 0.77 | SMN1; SMN2 (0.36) | LOXAOC3SMN1; SMN2LMNATSHR | |
| SCHEMBL5963881 | 0.77 | SMN1; SMN2 (0.36) | LOXAOC3SMN1; SMN2LMNATSHR | |
| SCHEMBL987278 | 0.76 | TSHR (0.44) | TSHRALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL8688535 | 0.75 | LMNA (0.39) | LOXAOC3SMN1; SMN2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9751899-B2 | Synthesis method of alkoxysilanes | LAINE RICHARD M (US) | 2017-09-05 | — | — | US | disclosed |
| US-9751899-B2 | Synthesis method of alkoxysilanes | LAINE RICHARD M (US) | 2017-09-05 | — | — | US | disclosed |
| US-20160304540-A1 | SYNTHESIS METHOD OF ALKOXYSILANES | LAINE RICHARD M (US) | 2016-10-20 | — | — | US | disclosed |
| US-20160304540-A1 | SYNTHESIS METHOD OF ALKOXYSILANES | LAINE RICHARD M (US) | 2016-10-20 | — | — | US | disclosed |
| EP-0789053-B1 | Stabiliser mixtures and their application in polycarbonates | BAYER AG (DE) | 2001-10-24 | — | — | EP | disclosed |
| EP-0789053-A1 | Stabiliser mixtures and their application in polycarbonates | BAYER AG (DE) | 1997-08-13 | — | — | EP | disclosed |
| EP-0507178-A2 | Stabilization of high temperature deformation resistant polycarbonate | BAYER AG (DE) | 1992-10-07 | — | — | EP | disclosed |
| US-4342681-A | Use of organic silicon compounds in combination with oxetane compounds, dioxanes or tetrahydrofuranes for stabilizing and brightening polycarbonates which are free from phosphites and free from boric acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1982-08-03 | — | — | US | disclosed |
| EP-0019217-A1 | Use of organic silicium compounds in combination with oxetane compounds, dioxanes or tetrahydrofuranes for the stabilisation and brightening of polycarbonates free from phosphites and boric acid esters | BAYER AG (DE) | 1980-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304540-A1 | SYNTHESIS METHOD OF ALKOXYSILANES | SIK2, S1PR4, SGPL1 | LOX 334/4885AOC3 383/4885SMN1; SMN2 2750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.